Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells

BACKGROUND: Cancer anemia causes fatigue and correlates with poor treatment outcome. Erythropoietin has been introduced in an attempt to correct these defects. However, five recent clinical trials reported a negative impact of erythropoietin on survival and/or tumor control, indicating that experime...

Full description

Saved in:
Bibliographic Details
Main Authors: Phillips, Tiffany M, Kim, Kwanghee, Vlashi, Erina, McBride, William H, Pajonk, Frank
Format: Artigo
Language:Inglês
Published: Neoplasia Press Inc. 2007
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2134908/
https://ncbi.nlm.nih.gov/pubmed/18084619
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items